'Cadila failed to record quality activities at API plant'
A recent warning letter issued by the US Food and Drug Administration to Cadila Healthcare's Moraiya facility points to failures in standard operating procedures, one of which notably is to thoroughly investigate unexplained discrepancy and failure of a batch to meet specifications.
READ MORE:
Other Corporate Videos
TCS screening candidates for C-suite rejig ahead; COO, CTO posts to be filled soon
Unicorn ed-tech firm Byju's lays off at least 1,000 more employees across various functions
Tata Trusts appoints Siddharth Sharma as CEO, Aparna Uppaluri as COO
Government to release standards for checking fake reviews on e-commerce, other platforms
Reliance retail, Adani group companies among bidders for Future Retail
